Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice

Adipose tissue (AT) inflammation and infiltration by macrophages is associated with insulin resistance and type 2 diabetes in obese humans, offering a potential target for therapeutics. However, whether AT macrophages (ATMs) directly contribute to systemic glucose intolerance has not been determined...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 110; no. 20; pp. 8278 - 8283
Main Authors: Aouadi, Myriam, Tencerova, Michaela, Vangala, Pranitha, Yawe, Joseph C., Nicoloro, Sarah M., Amano, Shinya U., Cohen, Jessica L., Czech, Michael P.
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 14-05-2013
National Acad Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adipose tissue (AT) inflammation and infiltration by macrophages is associated with insulin resistance and type 2 diabetes in obese humans, offering a potential target for therapeutics. However, whether AT macrophages (ATMs) directly contribute to systemic glucose intolerance has not been determined. The reason is the lack of methods to ablate inflammatory genes expressed in macrophages specifically localized within AT depots, leaving macrophages in other tissues unaffected. Here we report that i.p. administration of siRNA encapsulated by glucan shells in obese mice selectively silences genes in epididymal ATMs, whereas macrophages within lung, spleen, kidney, heart, skeletal muscle, subcutaneous (SubQ) adipose, and liver are not targeted. Such administration of GeRPs to silence the inflammatory cytokines TNF-α or osteopontin in epididymal ATMs of obese mice caused significant improvement in glucose tolerance. These data are consistent with the hypothesis that cytokines produced by ATMs can exacerbate whole-body glucose intolerance.
Bibliography:http://dx.doi.org/10.1073/pnas.1300492110
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: M.A. and M.P.C. conceptualized the study; M.A., M.T., P.V., J.C.Y., S.M.N., and M.P.C. designed research; M.A., M.T., P.V., J.C.Y., S.M.N., S.U.A., and J.L.C. performed research; S.U.A. and J.L.C. contributed new reagents/analytic tools; M.A., M.T., P.V., J.C.Y., S.M.N., and M.P.C. analyzed data; and M.A. and M.P.C. wrote the paper.
Edited* by Bruce M. Spiegelman, Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA, and approved April 5, 2013 (received for review January 9, 2013)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1300492110